Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Tips for Spending Holiday Time With Family Members Who Live with Dementia
SATURDAY, Dec. 21, 2024 -- The holiday spirit is infectious, even for people suffering from dementia. But family and friends might need to make some slight...
Frito-Lay Recalls Lay's Chips Due to Milk Allergy Concerns
FRIDAY, Dec. 20, 2024 -- Frito-Lay has recalled select 13-oz bags of Lay's Classic Potato Chips due to undeclared milk, which could pose a serious risk to...
Early Adoption of Tobacco 21 Policies Can Avert Premature Mortality
FRIDAY, Dec. 20, 2024 -- Early adoption and implementation of Tobacco 21 (T21) policies, with a minimum legal access age for tobacco products of 21 years, is...
High Acceptance Seen for Liver Stiffness Test With Routine Retina Scan in T2DM
FRIDAY, Dec. 20, 2024 -- For individuals with type 2 diabetes, examination with vibration-controlled transient elastography (VCTE) alongside retina scanning...
Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
FRIDAY, Dec. 20, 2024 -- Sexual minority women (SMW) report better sexual functioning in midlife than their heterosexual peers, according to a study published...
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to...
Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
FRIDAY, Dec. 20, 2024 -- An outbreak of salmonella linked to cucumbers has now been tied to 100 known cases of the illness across 23 states, the U.S. Food and...
Check Your Pantry, Lay's Classic Potato Chips Recalled Due to Milk Allergy Risk
FRIDAY, Dec. 20, 2024 -- Holy chip! Frito-Lay has issued a limited recall of select 13-oz bags of Lay’s Classic Potato Chips due to the potential...
Norovirus Sickens Hundreds on Three Cruise Ships: CDC
FRIDAY, Dec. 20, 2024 -- Just over 300 people have been sickened in norovirus outbreaks on three different cruise ships in December, new government data...
What's the Link Between Memory Problems and Sexism?
FRIDAY, Dec. 20, 2024 -- Sexism is incredibly toxic to women’s lives, resulting in lower pay, fewer career opportunities, worse health care and a greater...
FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound...
FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce Bleeding Episodes in People with Hemophilia A or B with Inhibitors
PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) approved Alhemo (concizumab-mtci)...
FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has...
U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome
Copenhagen, Denmark, December 19, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on...
FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases...
FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
CHATHAM, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that the U.S. Food...
Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug...
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative...
Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura
DURHAM, N.C., Nov. 26, 2024 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company, and its corporate parent, Shin Nippon...
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company...
Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)
TARRYTOWN, N.Y., December 19, 2024 – Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of...
Reported Use of Most Drugs Among Adolescents Remained Low in 2024
December 17, 2024 -- New NIH-funded data show lower use of most substances continues following the COVID-19 pandemic. If you or someone you know is...
FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
SALT LAKE CITY, Dec. 17, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to...
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
RAHWAY, N.J.--(BUSINESS WIRE) December 16, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.